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Brief Clinical ReportsLocalizing an occult gastrointestinal bleeding by wireless PillCam SB
capsule videoendoscopy in a patient with the HeartMate II left
ventricular assist deviceJ. F. Matthias Bechtel, MD,a Peter Wellho¨ner, MD,b Efstratios I. Charitos, MD,a Bence Bucsky, MD,a
Michiel Morshuis, MD,c and Hans H. Sievers, MD,a Lu¨beck and Bad O¨eynhausen, GermanyGastrointestinal bleeding is a known problem in patients
with left ventricular assist devices (LVADs). The exact
source of the bleeding is sometimes difficult to ascertain.
In gastroenterology, wireless capsule videoendoscopy has
become an important diagnostic tool, especially when the
small intestine is involved. It is not known, however,
whether an implanted LVAD would interfere with signal
transmission from the capsule, nor whether the signals
from the capsule would cause malfunction of the LVAD.
We report the case of a patient in whom significant gastroin-
testinal bleeding developed after implantation of a Heart-
Mate II LVAD (Thoratec Corporation, Pleasanton, Calif).
The source of the bleeding was successfully identified by
wireless PillCam SB capsule videoendoscopy (Given Imag-
ing Ltd, Yoqneam, Israel).FIGURE 1. Image taken with PillCam videocapsule endoscopy showing
diffuse bleeding in cecum without identifiable source. Preceding images
of terminal ileum and ileocecal valve were without signs of blood.CLINICAL SUMMARY
A 70-year-old man had a massive myocardial infarction
caused by occlusion of the left main coronary artery. Emer-
gency coronary artery bypass grafting was undertaken.
Shock was treated initially with a paracorporal centrifugal
pump (Centrimag; Levitronix LLC, Waltham, Mass) and
later with an intra-aortic balloon pump. The patient contin-
ued to require inotropic support and did not tolerate even
the lightest exertion. Because the patient had no neurologic
deficits or other known illnesses, we decided that he was
a suitable candidate for long-term support. Eleven days after
the myocardial infarction, implantation of a HeartMate II
LVAD was performed in a routine manner. The postopera-From the Departments for Cardiac and Thoracic Vascular Surgerya and Internal Med-
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The Journal of Thoracic and Cative course was largely uneventful, and the patient was dis-
charged home. For anticoagulation, phenprocoumon (target
international normalized ratio of 2.5) and clopidogrel (75 mg
every second day) were given.
Five months after implantation, the patient reported occa-
sional dark and foul-smelling defecations. Guaiac-based
fecal testing confirmed the presence of blood. Esophagogas-
troduodenoscopy revealed no pathologic findings. Clopi-
dogrel was discontinued. The patient felt well and went
home again. During the next weeks, however, the frequency
of melena increased and the hemoglobin concentration de-
creased. Colonoscopy was performed but revealed no path-
ologic findings. The patient was again discharged home, and
the target international normalized ratio was lowered to 2.0.
Melena persisted, however, and the hemoglobin concentra-
tion decreased to 72 g/L. The patient was hospitalized and
underwent transfusion with 3 units of packed red blood cells.
Inspection of the feces showed signs of fresh blood. There
were no hemorrhoids. Another colonoscopy was performed;rdiovascular Surgery c Volume 139, Number 4 e73
FIGURE 2. Image taken with conventional colonoscopy showing angio-
dysplasia in cecum with minimal bleeding signs.
Brief Clinical Reportsagain, however, the source of the bleeding could not be iden-
tified. Bleeding from the small intestine thus appeared to be
most likely. After conventional preparation, wireless capsule
videoendoscopy was performed with the PillCam SB. The
capsule consists of a small digital camera that takes 2 images
per second. These images are sent to an external receiver
through wireless technology. There were neither problems
with capsule passage through the gastrointestinal tract nor
with signal transmission, and no malfunction of the Heart-
Mate II occurred. Analysis of the data captured revealed
blood in the cecum (Figure 1) but not proximal to it in the
small intestine. Another colonoscopy was performed, and
two small angiodysplasias were found in the cecum (Fig-
ure 2) and successfully treated with argon plasma coagula-
tion and clipping. The patient was discharged home the
day after the procedure.DISCUSSION
Gastrointestinal bleeding is a known problem in patients
with LVADs, and its occurrence is promoted by the multiplee74 The Journal of Thoracic and Cardiovascular Surgmorbidities present in the supported patients and the need for
oral anticoagulation, usually in conjunction with antiplatelet
therapy. In addition, LVADs may cause an acquired von
Willebrand disease,1 resembling Heyde syndrome in aortic
stenosis,2 which is characterized by bleeding from gastroin-
testinal angiodysplasias. These vascular malformations may
be located anywhere in the gastrointestinal tract,3 and it thus
may be necessary to scan the small intestine for bleeding. In
this regard, wireless capsule videoendoscopy has become an
important diagnostic tool. There has only been a single re-
port in the literature on capsule endoscopy in patients with
LVADs,4 however, and that small report did not specify
the endoscopy system used. The concern arises that wireless
signal transmission from the capsule might be disturbed by
the electromagnetic field of the LVAD. Such considerations
are not totally speculative in light of reported adverse inter-
actions between the HeartMate II and a specific type of im-
plantable cardioverter–defibrillator.5
In retrospect, wireless capsule videoendoscopy may not
have been necessary in our case. Two previous had not iden-
tified the source of bleeding, however, probably because of
its intermittent nature. Wireless capsule videoendoscopy
was of great help in finding and treating the bleeding. No in-
teractions between the HeartMate II and the PillCam SB
were observed.References
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